Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
 
 
Email
mdccwj@nus.edu.sg
 
 

Publications

Results 161-180 of 184 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
1612016The emerging roles of exosomes in leukemogeneisZhou, J ; Wang, S; Sun, K; Chng, W.-J 
22018The genomics and molecular biology of natural killer/T-cell lymphoma: Opportunities for translationde Mel S.; Soon G.S.-T.; Mok Y.; Chung T.-H. ; Jeyasekharan A.D. ; Chng W.-J. ; Ng S.-B. 
330-Jun-2022The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.Blasiak, Agata ; Truong, Anh TL ; Remus, Alexandria ; Hooi, Lissa ; Seah, Shirley Gek Kheng; Wang, Peter ; Chye, De Hoe; Lim, Angeline Pei Chiew; Ng, Kim Tien; Teo, Swee Teng ; Tan, Yee-Joo ; Allen, David Michael ; Chai, Louis Yi Ann ; Chng, Wee Joo ; Lin, Raymond TP; Lye, David CB ; Wong, John Eu-Li ; Tan, Gek-Yen Gladys; Chan, Conrad En Zuo; Chow, Edward Kai-Hua ; Ho, Dean 
4Aug-2012The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study groupTan, D.; Ong, K.H.; Koh, L.P.; Wong, S.S.; Khin, M.T.; Lee, L.H.; Goh, Y.T.; Chng, W.J. 
5Sep-2013The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma networkTan, D.; Kim, K.; Kim, J.S.; Eom, H.-S.; Teoh, G.; Ong, K.H.; Goh, Y.T.; Durie, B.G.M.; Chng, W.J. ; Lee, J.H.
610-Mar-2010The Molecular Biology of Multiple MyelomaChng, W.J. ; Bergsagel, P.L.
77-May-2021The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2Lee, Kwok Kin ; Rajagopalan, Deepa; Bhatia, Shreshtha Sailesh; Tirado-Magallanes, Roberto; Chng, Wee Joo ; Jha, Sudhakar
82012The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaZhou J.; Cheong L.-L.; Liu S.-C.; Chong P.S.Y.; Mahara S.; Bi C.; Ong K.O.K.; Zeng Q.; Chng W.J. 
92018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G 
102016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K 
112014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
121-Feb-2022THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsShyamsunder, Pavithra ; Sridharan, Shree Pooja; Madan, Vikas ; Dakle, Pushkar ; Zeya, Cao; Kanojia, Deepika ; Chng, Wee-Joo ; Ong, S Tiong ; Koeffler, H Phillip
138-Jan-2019Towards understanding of PRC2 binding to RNAJunli Yan ; Bibek Dutta; Yan Ting Hee; Wee Joo Chng 
1417-Jan-2019Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disordersde Mel, Sanjay; Tan, Joshua Zhi-Chien; Jeyasekharan, Anand D ; Chng, Wee-Joo ; Ng, Siok-Bian 
151-Mar-2021Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupMoreau, Philippe; Kumar, Shaji K; Miguel, Jesus San; Davies, Faith; Zamagni, Elena; Bahlis, Nizar; Ludwig, Heinz; Mikhael, Joseph; Terpos, Evangelos; Schjesvold, Fredrik; Martin, Thomas; Yong, Kwee; Durie, Brian GM; Facon, Thierry; Jurczyszyn, Artur; Sidana, Surbhi; Raje, Noopur; Donk, Niels van de; Lonial, Sagar; Cavo, Michele; Kristinsson, Sigurdur Y; Lentzsch, Suzanne; Hajek, Roman; Anderson, Kenneth C; Joao, Cristina; Einsele, Hermann; Sonneveld, Pieter; Engelhardt, Monika; Fonseca, Rafael; Vangsted, Annette; Weisel, Katja; Baz, Rachid; Hungria, Vania; Berdeja, Jesus G; da Costa, Fernando Leal; Maiolino, Angelo; Waage, Anders; Vesole, David H; Ocio, Enrique M; Quach, Hang; Driessen, Christoph; Blade, Joan; Leleu, Xavier; Riva, Eloisa; Bergsagel, Peter Leif; Hou, Jian; Chng, Wee Joo ; Mellqvist, Ulf-Henrik; Dytfeld, Dominik; Harousseau, Jean-Luc; Goldschmidt, Hartmut; Laubach, Jacob; Munshi, Nikhil C; Gay, Francesca; Beksac, Meral; Costa, Luciano J; Kaiser, Martin; Hari, Parameswaran; Boccadoro, Mario; Usmani, Saad Z; Zweegman, Sonja; Holstein, Sarah; Sezer, Orhan; Harrison, Simon; Nahi, Hareth; Cook, Gordon; Mateos, Maria-Victoria; Rajkumar, S Vincent; Dimopoulos, Meletios A; Richardson, Paul G
161-Nov-2022Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple MyelomaWang, Samuel SY; Chng, Wee Joo ; Liu, Haiyan ; de Mel, Sanjay
172017Tumor-derived exosomes in colorectal cancer progression and their clinical applicationsZhou, J ; Li, X.-L; Chen, Z.-R; Chng, W.-J 
38Aug-2013Type II EATL (epitheliotropic intestinal T-cell lymphoma): A neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeTan, S.-Y. ; Chuang, S.-S.; Tang, T.; Tan, L.; Ko, Y.-H.; Chuah, K.-L.; Ng, S.-B. ; Chng, W.-J. ; Gatter, K.; Loong, F.; Liu, Y.-H.; Hosking, P.; Cheah, P.-L.; Teh, B.-T. ; Tay, K.; Koh, M.; Lim, S.-T. 
19Jul-2012Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study GroupTse, E.; Gill, H.; Loong, F.; Kim, S.J.; Ng, S.-B. ; Tang, T.; Ko, Y.-H.; Chng, W.-J. ; Lim, S.-T. ; Kim, W.S.; Kwong, Y.-L.
20Jan-2014Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfallsChan, E.H.L.; Lu, S.-J.; Petersson, F.; Tan, K.-B. ; Chng, W.-J. ; Ng, S.-B.